Emergent BioSolutions, Inc. (EBS) breakouts
Emergent BioSolutions, Inc., (EBS) a biopharmaceutical company, that, develops, manufactures, and commercializes immunobiotics in the United States, the United Kingdom, and Vietnam broke out on 2.5x its 21-day average volume. The company operates in two segments, Biodefense and Commercial. The Biodefense segment offers products for use against biological agents that are potential weapons of bioterrorism and biowarfare; and BioThrax, a vaccine for the prevention of anthrax infection.
 
With new military budgets approved and terrorism a constant threat we believe EBS's point and figure target of 17.50 is very feasible.
 

Comments
Leave a comment
Name
Email Address
URL
Remember personal info?
Comments
Blog Home
RSS Feed
Categories
Barron's
Breakouts/Breakdowns
ChartWatch
Company in the News
Earnings
Equity Timing Signals (Buy/Sell)
Index Study
Market Data
Media
New Highs
Sector Group Rankings
Short Squeeze Screen
Stock Analysis
Total Stocks Rankings
Archives
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007